AFTER THE rescue of the Cara Pharmacy group of companies back in 2020, the latest figures for the new holding company suggest it may be some time before the backers see a return, although at least the directors’ fees will help the medicine go down. The Cara group was the brainchild of Ramona Nicholas. Unlike… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!